<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39359436</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>04</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2008-6164</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Season>Fall</Season></PubDate></JournalIssue><Title>Caspian journal of internal medicine</Title><ISOAbbreviation>Caspian J Intern Med</ISOAbbreviation></Journal><ArticleTitle>Serum tumor necrosis factor-alpha status in hospitalized patients with coronavirus disease-2019 (COVID-19).</ArticleTitle><Pagination><StartPage>601</StartPage><EndPage>605</EndPage><MedlinePgn>601-605</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.22088/cjim.15.4.601</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Tumor necrosis factor alpha (TNF-α) produces an inflammatory process and plays a critical role against infection and in the control of viral infection. The present study was conducted to determine the status of serum TNF-α in hospitalized patients with coronavirus disease-2019 (COVID-19).</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">In this cross-sectional study the serum TNF-α level, sex, and age, were determined in patients with COVID-19. The association between variables was determined using the student t-test, analysis of variance (ANOVA) test, multiple logistic regression analysis, and the statistical package for the Social Sciences (SPSS)-18 (p &lt; 0.05).</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 91 (women 41.75%, and men 58.24%) patients with a mean serum TNF-α level of 9.9 picograms per milliliter (pg/mL) were considered. In all (100%) patients, the TNF-α serum level was more than the normal limit (P=0.95). 95.60% of patients suffered severe COVID-19, with a TNF-a serum level of 10.20 pg/mL (P=0.87). Mean TNF-α serum levels in women and men were 11.37 pg/mL and 8.8 pg/mL, respectively (P= 0.17). In the age group of &gt; 70 years (11.30 pg/mL), serum TNF-α concentration was higher than the other age groups (p&gt;0.05).</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">A significant proportion of women and men patients with COVID-19 in the middle and old age had a high concentration of serum TNF-α which may indicate the severity of the disease. Serum TNF-α level is different in women and men of different ages, so it can contribute to treatment strategies.</AbstractText><CopyrightInformation>© The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Babaei</LastName><ForeName>Mansour</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Mobility Impairment Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Research Development Unit of Ayatollah Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heidari</LastName><ForeName>Behzad</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Mobility Impairment Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Clinical Research Development Unit of Ayatollah Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sadeghi Haddad Zavareh</LastName><ForeName>Mahmoud</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Clinical Research Development Unit of Ayatollah Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahmadnia</LastName><ForeName>Zahra</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Clinical Research Development Unit of Ayatollah Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ghorbani</LastName><ForeName>Hossein</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Clinical Research Development Unit of Ayatollah Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rouhi</LastName><ForeName>Samaneh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Clinical Research Development Unit of Ayatollah Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>Iran</Country><MedlineTA>Caspian J Intern Med</MedlineTA><NlmUniqueID>101523876</NlmUniqueID><ISSNLinking>2008-6164</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Coronavirus disease (COVID-19)</Keyword><Keyword MajorTopicYN="N">Hospitalized patients</Keyword><Keyword MajorTopicYN="N">Tumor necrosis factor-alpha (TNF-α)</Keyword></KeywordList><CoiStatement>The authors declare that there is no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>4</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>30</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39359436</ArticleId><ArticleId IdType="pmc">PMC11444111</ArticleId><ArticleId IdType="doi">10.22088/cjim.15.4.601</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Smail SW, Babaei E, Amin K, Abdulahad WH. Serum IL-23, IL-10, and TNF-α predict in-hospital mortality in COVID-19 patients. Front Immunol. 2023;14:1145840.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10239952</ArticleId><ArticleId IdType="pubmed">37283736</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebrahimi S, Kalantari S, Rahmani Fard S, et al. Evaluation of relationship between the level of inflammatory cytokines interleukin-10 and tumor necrosis factor-alpha with virologic response to treatment in patients with HIV. Tehran Univ Med J. 2022;80:91–8.</Citation></Reference><Reference><Citation>Bernardi S, Toffoli B, Tonon F, et al. Sex differences in proatherogenic cytokine levels. Int J Mol Sci. 2020;21:3861.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7311959</ArticleId><ArticleId IdType="pubmed">32485823</ArticleId></ArticleIdList></Reference><Reference><Citation>Martínez de Toda I, González-Sánchez M, Díaz-Del Cerro E, et al. Sex differences in markers of oxidation and inflammation. Implications for ageing. Mech Ageing Dev. 2023;211:111797.</Citation><ArticleIdList><ArticleId IdType="pubmed">36868323</ArticleId></ArticleIdList></Reference><Reference><Citation>Zelová H, Hošek J. TNF-α signalling and inflammation: interactions between old acquaintances. Inflamm Res . 2013;62:641–51.</Citation><ArticleIdList><ArticleId IdType="pubmed">23685857</ArticleId></ArticleIdList></Reference><Reference><Citation>Akbari H, Tabrizi R, Lankarani KB, et al. The role of cytokine profile and lymphocyte subsets in the severity of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. Life Sci. 2020;258:118167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7387997</ArticleId><ArticleId IdType="pubmed">32735885</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497–506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin C, Zhou L, Hu Z, et al. Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Arch Clin Infect Dis . 2020;71:762–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7108125</ArticleId><ArticleId IdType="pubmed">32161940</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G, Wu D, Guo W, et al. Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest. 2020;130:2620–9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7190990</ArticleId><ArticleId IdType="pubmed">32217835</ArticleId></ArticleIdList></Reference><Reference><Citation>Diao B, Wang C, Tan Y, et al. Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19) Front immunol . 2020;11:827.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7205903</ArticleId><ArticleId IdType="pubmed">32425950</ArticleId></ArticleIdList></Reference><Reference><Citation>Soy M, Keser G, Atagündüz P, et al. Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment. Clin Rheumatol. 2020;39:2085–94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7260446</ArticleId><ArticleId IdType="pubmed">32474885</ArticleId></ArticleIdList></Reference><Reference><Citation>Han H, Ma Q, Li C, et al. Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors. Emerg Microbes Infect. 2020;9:1123–30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7473317</ArticleId><ArticleId IdType="pubmed">32475230</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L, Li TS. Interpretation of “guidelines for the diagnosis and treatment of novel coronavirus (2019-nCoV) infection by the National Health Commission (Trial Version 5)”. Zhonghua Yi Xue Za Zhi . 2020;100:E001.</Citation><ArticleIdList><ArticleId IdType="pubmed">32033513</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang X, Yin Z, Wang T, et al. COVID-19 dynamic computed tomography (CT) performance and observation of some laboratory indicators. Med Sci Monit. 2020;26:e924403.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7218963</ArticleId><ArticleId IdType="pubmed">32367888</ArticleId></ArticleIdList></Reference><Reference><Citation>Funama Y, Awai K, Liu D, et al. Detection of nodules showing ground-glass opacity in the lungs at low-dose multidetector computed tomography: phantom and clinical study. J Comput Assist Tomogr. 2009;33:49–53.</Citation><ArticleIdList><ArticleId IdType="pubmed">19188784</ArticleId></ArticleIdList></Reference><Reference><Citation>Corman VM, Landt O, Kaiser M, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill. 2020;25:2000045.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6988269</ArticleId><ArticleId IdType="pubmed">31992387</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrescu F, Voican SC, Silosi I. Tumor necrosis factor-alpha serum levels in healthy smokers and nonsmokers. Int J Chron Obstruct Pulmon Dis. 2010 Aug;5:217–22.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2921689</ArticleId><ArticleId IdType="pubmed">20714375</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Valle DM, Kim-Schulze S, Huang H-H, et al. An inflammatory cytokine signature predicts COVID-19 severity and survival. Nat Med . 2020;26:1636–43.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7869028</ArticleId><ArticleId IdType="pubmed">32839624</ArticleId></ArticleIdList></Reference><Reference><Citation>Tzanavari T, Giannogonas P, Karalis KP. TNF-alpha and obesity. Curr Dir Autoimmun. 2010;11:145–56.</Citation><ArticleIdList><ArticleId IdType="pubmed">20173393</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebrahimi AA, Noshad H, Sadreddini S, et al. Serum levels of TNF-alpha, TNF-alphaRI, TNF-alphaRII and IL-12 in treated rheumatoid arthritis patients. Iran J Immunol. 2009;6:147–53.</Citation><ArticleIdList><ArticleId IdType="pubmed">19801788</ArticleId></ArticleIdList></Reference><Reference><Citation>Li G, Wu W, Zhang X, et al. Serum levels of tumor necrosis factor alpha in patients with IgA nephropathy are closely associated with disease severity. BMC Nephrol. 2018;19:326.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6236996</ArticleId><ArticleId IdType="pubmed">30428849</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong M, Ziring D, Korin Y, et al. TNFα blockade in human diseases: mechanisms and future directions. Clin Immunol. 2008;126:121–36.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2291518</ArticleId><ArticleId IdType="pubmed">17916444</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>